
Indivi Raises CHF15 Million to Advance Biomarker Discovery for Alzheimer’s and Neuroscience Drug Development
Indivi Secures CHF 15 Million to Advance Biomarker Discovery in Alzheimer’s and Neuroscience Drug Development Indivi, an independent TechBio company pioneering precision medicine solutions for neuroscience, today announced the successful closing of a CHF 15 million investment round led by…

Aptar to Showcase Innovation at Jefferies Global Healthcare Conference 2025
Aptar to Present at Jefferies Global Healthcare Conference on November 19, 2025 a global leader in drug delivery, consumer product dosing, dispensing, and protection technologies, today announced its participation in the Jefferies Global Healthcare Conference, taking place on Wednesday, November…

RadNet Acquires CIMAR UK to Boost DeepHealth’s AI-Powered Imaging and Diagnostic Capabilities
RadNet’s strategic move boosts DeepHealth’s innovation in AI-powered medical imaging and reporting RadNet, Inc., a US leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, announced today the acquisition of CIMAR UK, a leading provider of cloud-native…

Despite Government Shutdown, Stepful Maintains Free Training for Military Families
Stepful Maintains Free Healthcare Training for Military Families Amid Government Shutdown As the ongoing government shutdown continues to interrupt funding for critical education and workforce development programs, Stepful—recognized as the #1 EdTech company in the U.S. by TIME Magazine and…

Concentra Opens New Occupational Medical Center in Union City, Georgia
Concentra, the nation’s leader in occupational medicine and a part of Select Medical has announced the opening of a new medical center in Union City, Georgia The new facility, known as its Union City, will serve employers and employees in…

RadNet Announces Strong Q3 Results with Record Revenue and Adjusted EBITDA; Raises 2025 Financial Guidance
RadNet Reports Record Q3 2025 Results and Raises Full-Year Guidance a leading national provider of high-quality outpatient diagnostic imaging services and global developer of digital health solutions, announced strong financial results for the third quarter of 2025, delivering record revenue,…

Robotic Surgery Corrects Congenital Kidney Pelvis Deformity at Al Mouwasat Hospital in Al Khobar
A highly skilled surgical team successfully treats a rare ureteral obstruction using advanced robotic-assisted technology. In a remarkable medical achievement, the surgical team at Al Mouwasat hospital in Al Khobar has successfully performed a highly delicate robotic-assisted procedure to correct…

Gizmo Medical Transforms OEM Collaborations with Tailor-Made Surgical System Solutions
Gizmo Medical Expands Global Manufacturing to Redefine OEM Partnerships with Custom, End-to-End Surgical Systems Gizmo Medical, a global leader in orthopedic and surgical instrumentation design and production management, is transforming how Original Equipment Manufacturers (OEMs) collaborate and innovate. By delivering…

CareDx Announces Equity Inducement Grants in Accordance with Nasdaq Listing Rule 5635(c)(4)
CareDx Announces Inducement Equity Grants to New Employees and Chief Medical Officer Under Nasdaq Listing Rule 5635(c)(4) CareDx, Inc. widely recognized as The Transplant Company™, has announced a new round of equity inducement grants to strengthen its leadership team and…

Novanta Inc. Prices $550 Million Offering of Tangible Equity Units
Novanta Prices $550 Million Tangible Equity Units Offering to Bolster Financial Flexibility and Drive Growth Initiatives Novanta Inc. (Nasdaq: NOVT), a leading global technology partner serving medical and advanced technology equipment manufacturers, announced that it has successfully priced its previously…

Biomunex to Showcase Preclinical Findings on Its MAIT Engager Immuno-Oncology Platform at the 2025 SITC Annual Meeting
Biomunex to Present Breakthrough Preclinical Data on Its MAIT Engager Immuno-Oncology Platform at the 2025 SITC Annual Meeting Biomunex Pharmaceuticals, a French biopharmaceutical company advancing the frontiers of cancer immunotherapy through its pioneering bispecific and multispecific antibody technologies, has announced…

Evinova China, Harbour BioMed Partner on AI Drug Development
Evinova China and Harbour BioMed Form Strategic AI Partnership to Advance Biologic Drug Development and Global Innovation During the 8th China International Import Expo (CIIE), two global leaders in the life sciences and biopharmaceutical industries—Evinova, a digital health and technology…
